CADL - Candel Therapeutics Inc
IEX Last Trade
6.75
0.370 5.481%
Share volume: 342,735
Last Updated: Fri 30 Aug 2024 09:59:28 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.38
0.37
5.80%
Summary score
15%
Profitability
0%
Dept financing
12%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.95%
Return on assets
-12.49%
Return on sales
-27797.43%
Return on invested capital
-5294%
Total debt ratio
41.82%
Debt ratio change over timeo
-0.98%
Current Ratio
11.61%
Quick Ratio
11.61%
Cash Position Ratio
11.34%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.18%
Return on assets
-14.69%
Return on sales
-25318.75%
Return on invested capital
-2576.73%
Total debt ratio
45.3%
Debt ratio change over timeo
-0.96%
Current Ratio
8.88%
Quick Ratio
8.88%
Cash Position Ratio
8.58%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-36.64%
Return on assets
-17.7%
Return on sales
0%
Return on invested capital
157.16%
Total debt ratio
54.01%
Debt ratio change over time
-1.27%
Current Ratio
4.37%
Quick Ratio
4.37%
Cash Position Ratio
4.16%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-101.02%
Return on assets
-100.7%
Return on sales
377.09%
Return on invested capital
-276.84%
Total debt ratio
-98.25%
Debt ratio change over time
-0.98%
Current Ratio
-0.37%
Quick Ratio
-0.37%
Cash Position Ratio
-0.39%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CADL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.95% | 7.58% | 36.15% | 7.75% |
| Return on assets | -12.49% | 2.95% | 3.44% | 5.85% |
| Return on sales | -27797.43% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | -5294% | 3.7% | 6.05% | 20.44% |
| Profitability | 0% | 41% | 68% | 80% |
| Total debt ratio | 41.82% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -0.98% | 292.67% | 15.45% | 1.02% |
| Dept financing | 11% | 50% | 25% | 7% |
| Current Ratio | 8.88% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 8.88% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 8.58% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 6% | 10% | 21% |
| Short-term ratios | CADL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25.18% | 11.57% | 35.05% | 4.21% |
| Return on assets | -14.69% | 2.86% | 2.7% | 3.6% |
| Return on sales | -25318.75% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | -2576.73% | 2.16% | 6.93% | 9.79% |
| Profitability | 0% | 54% | 85% | 78% |
| Total debt ratio | 45.3% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -0.96% | 102.83% | 13.09% | 1.3% |
| Dept financing | 12% | 49% | 28% | 6% |
| Current Ratio | 8.88% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 8.88% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 8.58% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 6% | 18% | 36% |